Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penny L Moore

Showing results (41-50 of 214) with videos related to

Pageof 22
Sort By:
AIDS Research and Human Retroviruses|December 31, 2021
Biomarkers of Endothelial Activation in Black South African HIV-Positive Subjects are Associated with Both High Viral Load and Low CD4 CountsGenevieve Mezoh, Nereshni Lutchman, Catherine Worsley, et al.
Journal of Virology|October 18, 2019
Neutralization Breadth and Potency of Single-Chain Variable Fragments Derived from Broadly Neutralizing Antibodies Targeting Multiple Epitopes on the HIV-1 EnvelopeRebecca T van Dorsten, Bronwen E Lambson, Constantinos Kurt Wibmer, et al.
Frontiers in Immunology|May 6, 2022
Influenza Vaccination Results in Differential Hemagglutinin Stalk-Specific Fc-Mediated Functions in Individuals Living With or Without HIVBoitumelo M Motsoeneng, Nisha Dhar, Marta C Nunes, et al.
The Journal of Infectious Diseases|May 14, 2024
Hemagglutinin Stalk-Specific Fc-Mediated Functions Are Associated With Protection Against Influenza Illness After Seasonal Influenza VaccinationBoitumelo M Motsoeneng, Nisha Dhar, Marta C Nunes, et al.
Plos Pathogens|January 26, 2018
Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineageLucia Reh, Carsten Magnus, Claus Kadelka, et al.
Frontiers in Immunology|September 27, 2021
HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector FunctionSimone I Richardson, Frances Ayres, Nelia P Manamela, et al.
Journal of Virology|June 27, 2022
HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing AntibodiesDaniel J Sheward, Tandile Hermanus, Ben Murrell, et al.
Immunity, Inflammation and Disease|March 27, 2024
Preventing breast milk HIV transmission using broadly neutralizing monoclonal antibodies: One size does not fit allPhilippe Van de Perre, Gabriella Scarlatti, Penny L Moore, et al.
Human Antibodies|May 25, 2006
Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralizationEmma T Crooks, Penny L Moore, Douglas Richman, et al.
Journal of Virology|December 21, 2007
4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody responseElin S Gray, Penny L Moore, Frederic Bibollet-Ruche, et al.
Pageof 22

Showing results (41-50 of 214) with videos related to

Sort By:
Pageof 22
AIDS Research and Human Retroviruses|December 31, 2021
Biomarkers of Endothelial Activation in Black South African HIV-Positive Subjects are Associated with Both High Viral Load and Low CD4 CountsGenevieve Mezoh, Nereshni Lutchman, Catherine Worsley, et al.
Journal of Virology|October 18, 2019
Neutralization Breadth and Potency of Single-Chain Variable Fragments Derived from Broadly Neutralizing Antibodies Targeting Multiple Epitopes on the HIV-1 EnvelopeRebecca T van Dorsten, Bronwen E Lambson, Constantinos Kurt Wibmer, et al.
Frontiers in Immunology|May 6, 2022
Influenza Vaccination Results in Differential Hemagglutinin Stalk-Specific Fc-Mediated Functions in Individuals Living With or Without HIVBoitumelo M Motsoeneng, Nisha Dhar, Marta C Nunes, et al.
The Journal of Infectious Diseases|May 14, 2024
Hemagglutinin Stalk-Specific Fc-Mediated Functions Are Associated With Protection Against Influenza Illness After Seasonal Influenza VaccinationBoitumelo M Motsoeneng, Nisha Dhar, Marta C Nunes, et al.
Plos Pathogens|January 26, 2018
Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineageLucia Reh, Carsten Magnus, Claus Kadelka, et al.
Frontiers in Immunology|September 27, 2021
HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector FunctionSimone I Richardson, Frances Ayres, Nelia P Manamela, et al.
Journal of Virology|June 27, 2022
HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing AntibodiesDaniel J Sheward, Tandile Hermanus, Ben Murrell, et al.
Immunity, Inflammation and Disease|March 27, 2024
Preventing breast milk HIV transmission using broadly neutralizing monoclonal antibodies: One size does not fit allPhilippe Van de Perre, Gabriella Scarlatti, Penny L Moore, et al.
Human Antibodies|May 25, 2006
Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralizationEmma T Crooks, Penny L Moore, Douglas Richman, et al.
Journal of Virology|December 21, 2007
4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody responseElin S Gray, Penny L Moore, Frederic Bibollet-Ruche, et al.
Pageof 22